ARMP
$4.52
Armata Pharmaceuticals
$.30
7.11%
ARMP
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus:  ($0.26)
Revenue:  N/A
Thursday
Aug 11
4:15 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ARMP reports earnings?
Beat
Meet
Miss

Where is ARMP's stock price going from here?
Up
Flat
Down
Stock chart of ARMP
Analysts
Summary of analysts' recommendations for ARMP
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. It is also developing and advancing a pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa. Armata Pharmaceuticals Inc., formerly known as AmpliPhi Biosciences Corporation, is based in Marina del Rey, California.